Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 3-Bromopentane | HCID 15738 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | (3S,5R,6S)-3-allyl-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-cyclopropyl-2-mercaptoethyl)-3-methylpiperidin-2-one | HCID 86660746 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 67999759 | HCID 67999759 | — |
Reaction Steps
To a solution of (3S,5R,6S)-3-allyl-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-cyclopropyl-2-mercaptoethyl)-3-methylpiperidin-2-one (49 mg, 0.10 mmol; Example 366, Step A) and 3-bromopentane (51 μl, 0.41 mmol) in DMF (0.52 mL) was added 60% sodium hydride in mineral oil (17 mg, 0.41 mmol) at 25° C. The reaction was stirred at 25° C. for 1 h and then heated to 60° C. After being stirred at 60° C. overnight, the reaction was quenched (10% aq. citric acid), extracted (2×EtOAc), and washed (3× brine). The combined organic layers were dried (Na2SO4) and concentrated under reduced pressure. Purification of the residue by chromatography on silica gel (4 g SiO2, 9% and 18% EtOAc/hex) provided the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09296736B2 |
|---|
| Source dataset | uspto-grants-2016_03 |
|---|
| ORD ID | ord-c6ee1f8e47ef4e95a5e3aa8ba20f40c5 |
|---|
| Source note | uspto-grants-2016_03 |
|---|